Lv1
40 积分 2024-09-06 加入
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1天前
已完结
C3 glomerulopathy: advancements in diagnostics and therapeutics
9天前
已完结
Telitacicept targets Gd-IgA1 and autoantibody-producing B cells in IgA nephropathy
15天前
已完结
Risk acceleration by gout on major adverse cardiovascular events and all‐cause death in patients with diabetes and chronic kidney disease
2个月前
已完结
Trends in nephrology: kidney metabolism as a therapeutic target
2个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2个月前
已完结
Prevalence of Chronic Kidney Disease in China
2个月前
已完结
Prevalence of Chronic Kidney Disease in China
2个月前
已完结
Prevalence and patterns of multimorbidity in China during 2002–2022: A systematic review and meta-analysis
2个月前
已完结
Screening for Retinal Ischemic Perivascular Lesions in Patients Undergoing Cardiovascular Assessment
2个月前
已完结
皖公网安备34019202002308
